Asian Journal of Biochemistry1815-99231815-9931Academic Journals Inc.10.3923/ajb.2007.256.262HuqFazlul 4200724In this study, molecular modelling analyses based on molecular mechanics, semi-empirical (PM3) and DFT (at B3LYP/6-31G* level) have been carried out for troglitazone (TGZ) and its metabolites with the aim of obtaining information on their relative toxicity. The results of the analyses show that TGZ and its metabolites have LUMO-HOMO energy differences ranging from 4.1 to 4.9 eV from DFT calculations except TGZQ which has much lower value of 2.69 eV. The values suggest although TGZ and most of its metabolites would be kinetically inert, the metabolite TGZQ would be highly labile. The molecular surfaces of TGZ and its metabolites are found to abound in neutral (green) and electron-rich (red and yellow) regions so that the compounds may undergo lyophilic and electrophilic attacks. TGZ and all its metabolites also possess some electron-deficient regions so that they may be subject to nucleophilic attacks by glutathione and nucleobases as well. However, the rates of such adverse reactions are expected to be low for TGZ and its metabolites except in the case of the highly labile metabolite TGZQ.]]>Christiansen, M.P., P.A. Linfoot, R.A. Neese and M.K. Hellerstein,20004916911699Enokizono, E., H. Kushura and Y. Sugiyama,200635209214Funk, C., C. Ponelle, G. Scheuermann and M. Pantze,2001In vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.]]>59627635Gan, J., T.W. Harper, M.M. Hsueh, Q. Qu and W.G. Humphreys,200518896903He, K., R.E. Talaat, W.F. Pool, M.D. Reily, J.E. Reed, A.J. Bridges and T.F. Woolf,200432639646Hollenback, C.B., N. Chen, Y.D.I. Chen and G.M. Reaven,198433460463Huq, F. and A. Alshehri,20061359373Huq, F.,20061155163Huq, F.,20061328336Kassahun, K., P.G. Pearson, W. Tang, I. McIntosh, K. Leung, C. Elmore, D. Dean, R. Wang, G. Doss and T.A. Baillie,2001in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission.]]>146270Kirchheiner, J., I. Roots, M. Goldammer, B. Rosenkranz and J. Brockmoller,2005450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: Clinical relevance.]]>4412091225Lehmann, J.M., L.B. Moore, T.A. Smith-Oliver, W.O. Wilkinson, T.M. Wilson and S.A. Kliewer,19952701295312956Pessayre, D. and D. Larrey,19882385422Robinson, A.C.J., J.A.R. Jeffs, R.G. Gray, P.A. Bannister, H. Mether, J.J. Gallagher, S. Robinson, M. Nattrass, S. Venkatesan, D. Halliday and D.G. Johnston,2004342936Salitel, A.R. and J.M. Olefsky,19964516611669Spartan,2002Taratani, P.A., L.J. Baier, G. Paolisso, B.V. Howard and E. Ravussin,199631267270